Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zubeida Salaam-Dreyer"'
Autor:
Helen Cox, ProfPhD, Zubeida Salaam-Dreyer, PhD, Galo A Goig, PhD, Mark P Nicol, ProfPhD, Fabrizio Menardo, PhD, Anzaan Dippenaar, PhD, Erika Mohr-Holland, MPH, Johnny Daniels, BA, Patrick G T Cudahy, PhD, Sonia Borrell, PhD, Miriam Reinhard, MD, Anna Doetsch, MSc, Christian Beisel, PhD, Anja Reuter, MD, Jennifer Furin, MD, Sebastien Gagneux, ProfPhD, Robin M Warren, ProfPhD
Publikováno v:
The Lancet Microbe, Vol 2, Iss 11, Pp e584-e593 (2021)
Summary: Background: South Africa has a high burden of rifampicin-resistant tuberculosis (including multidrug-resistant [MDR] tuberculosis), with increasing rifampicin-monoresistant (RMR) tuberculosis over time. Resistance acquisition during first-li
Externí odkaz:
https://doaj.org/article/eabc95b2fba449618f5b7dcb2a25c8ac
Autor:
Helen Cox, Galo A. Goig, Zubeida Salaam-Dreyer, Anzaan Dippenaar, Anja Reuter, Erika Mohr-Holland, Johnny Daniels, Patrick G. T. Cudahy, Mark P. Nicol, Sonia Borrell, Miriam Reinhard, Anna Doetsch, Christian Beisel, Sebastien Gagneux, Robin M. Warren, Jennifer Furin
Publikováno v:
Journal of Clinical Microbiology, 60 (3)
Journal of clinical microbiology
Journal of clinical microbiology
Treatment of multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB), although improved in recent years with shorter, more tolerable regimens, remains largely standardized and based on limited drug susceptibility testing (DST). More indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac477d52e0080735bee8de4239da64d
https://hdl.handle.net/20.500.11850/543517
https://hdl.handle.net/20.500.11850/543517
Autor:
Johnny Daniels, Sebastien Gagneux, Jennifer Furin, Fabrizio Menardo, Christian Beisel, Mark P. Nicol, Anzaan Dippenaar, Galo A Goig, Anja Reuter, Sonia Borrell, Anna Doetsch, Erika Mohr-Holland, Patrick G T Cudahy, Miriam Reinhard, Robin M. Warren, Zubeida Salaam-Dreyer, Helen Cox
Publikováno v:
The Lancet. Microbe
The Lancet Microbe, Vol 2, Iss 11, Pp e584-e593 (2021)
The Lancet microbe
The Lancet Microbe, Vol 2, Iss 11, Pp e584-e593 (2021)
The Lancet microbe
Summary Background South Africa has a high burden of rifampicin-resistant tuberculosis (including multidrug-resistant [MDR] tuberculosis), with increasing rifampicin-monoresistant (RMR) tuberculosis over time. Resistance acquisition during first-line
Autor:
Sebastien Gagneux, Miriam Reinhard, Fabrizio Menardo, Helen Cox, Elizabeth M. Streicher, Mark P. Nicol, Anna Doetsch, Patrick G T Cudahy, Anzaan Dippenaar, Johnny Daniels, Zubeida Salaam-Dreyer, Robin M. Warren, Erika Mohr-Holland, Frederick A. Sirgel, Sonia Borrell
Rifampicin mono-resistant TB (RMR-TB) constitutes 38% of all rifampicin-resistant TB (RR-TB) in South Africa and is increasing. We aimed to compare RMR-TB with multidrug-resistant TB (MDR-TB) within a high TB, RR-TB and HIV burden setting. Patient-le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaf9df22e64a94a73eb638613d2c2f58
https://doi.org/10.1101/2021.06.14.21258812
https://doi.org/10.1101/2021.06.14.21258812
Autor:
Sebastien Gagneux, Helen Cox, Anzaan Dippenaar, Sonia Borrell, Frederick A. Sirgel, Zubeida Salaam-Dreyer, Mark P. Nicol, Erika Mohr-Holland, Elizabeth M. Streicher, Robin M. Warren, Anna Doetsch, Patrick G T Cudahy, Miriam Reinhard, Fabrizio Menardo, Johnny Daniels
Publikováno v:
Antimicrobial agents and chemotherapy
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
Rifampin monoresistance (RMR; rifampin resistance and isoniazid susceptibility) accounts for 38% of all rifampin-resistant tuberculosis (RR-TB) in South Africa and is increasing. We aimed to compare RMR-TB with multidrug-resistant TB (MDR-TB) in a se
Autor:
Zubeida Salaam Dreyer, Edward Makgotlho, Bhanu Sinha, Elizabeth Wasserman, Wilhelm Oosthuysen, Heidi Orth
Publikováno v:
Southern African Journal of Epidemiology and Infection, 28(1), 22-27
To elucidate the local epidemiology of Staphylococcus aureus bacteraemia, we characterised blood culture isolates using molecular methods and prospectively collected clinical data to determine the occurrence of community-acquired, methicillinresistan